Clinical trial CADPT01C12101
A Phase Ib multicenter, open-label dose escalation and expansion platform study of selected drug combinations in adult patients with advanced or metastatic BRAF V600 colorectal cancer
Cancers | |
---|---|
Organ | Colon |
Trial status | Trial closed |
Investigator | |
Trial type |
Interventional with experimental drug
|
Phase | Trial phase 1/1b |
Academic trial | Non |
Sponsor | Novartis |
EudraCT Identifier | 2019-004688-27 |
ClinicalTrials.gov | https://clinicaltrials.gov/ct2/show/NCT04294160 |
Last update |